Drrx stock forecast.

Find the latest DURECT Corporation (DRRX) stock quote, history, news and other vital information to help you with your stock trading and investing. Alzamend Neuro® is a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease, Bipolar disorder, Major Depressive Disorder (“MDD”) and Post-Traumatic Stress Disorder (“PTSD”). Our mission is to rapidly develop and market safe and effective treatments to bring aid to the 43 ...Durect Corp Price (DRRX) Daily Price Prediction ChartsForecst.com predicts future values using technical analysis of a large number of analytical parameters. DRRX stock returns are also predicted based on historical data. According to our research, DRRX stock is a not so good long-term investment. DRRX share price has been in a bull cycle for the past year.DRRX Stock USD 6.40 0.02 0.31% Durect stock price prediction is an act of determining the future value of Durect shares using few different conventional methods such as EPS estimation , analyst consensus, or fundamental intrinsic valuation .

Institutional Ownership and Shareholders. Durect Corp (US:DRRX) has 4 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 404,520 shares. Largest shareholders include Jefferies Group LLC, Montchanin Asset Management, Llc, and Regis …

Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.

DURECT (DRRX) Stock Forecast & Price Target $0.64 +0.01 (+1.03%) (As of 02:51 PM ET) Compare Today's Range $0.59 $0.65 50-Day Range $0.53 $2.98 52 …Get the latest Dare Bioscience Inc (DARE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Durect Stock Prediction. AVB. 40Wall Street Analysts Think Durect (DRRX) Could Surge 594.98%: Read This Before Placing a Bet Zacks - Thu May 11, 8:55AM CDT . The mean of analysts' price targets for Durect (DRRX) points to a 595% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in...

Weather forecasting plays a crucial role in our daily lives, helping us plan our activities and make informed decisions. But have you ever wondered how meteorologists are able to accurately predict the weather? One of the key components in ...

Let’s talk about penny stocks. These are equities that trade for less than $5 per share, at the very bottom of the price range. While they are priced that low for a reason – and the reasons may vary – a low price in itself doesn’t mean that the stock’s fundamentals are sour. Smart investors […]

GEVO Stock 12 Months Forecast. $6.47. (528.16% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Gevo in the last 3 months. The average price target is $6.47 with a high forecast of $14.00 and a low forecast of $2.00. The average price target represents a 528.16% change from the last price of $1.03.... DURECT · Dutch Bros · D-Wave Quantum · DXC Technology Company · DXP Enterprises · Dyadic International · Dycom Industries · Dynagas LNG Partners LP · Dynatrace.SNBR Stock Outlook. Sleep Number updated its outlook for the full year of 2023 in its latest earnings report as well. It now expects diluted EPS to be up to -70 cents while revenue will decrease ...DRRX stock has a “B” rating in the Portfolio Grader. Dynavax Technologies (DVAX) Dynavax Technologies DVAX is a commercial-stage biotech company focusing is on getting drugs over the finish line (approval from the Food & Drug Administration and other regulators in other countries) and available for sale.Nov 13, 2023 · Past Earnings Growth Analysis. Earnings Trend: DRRX is unprofitable, and losses have increased over the past 5 years at a rate of 17.7% per year. Accelerating Growth: Unable to compare DRRX's earnings growth over the past year to its 5-year average as it is currently unprofitable. Earnings vs Industry: DRRX is unprofitable, making it difficult ... Analyst Price Forecast Suggests 670.31% Upside. As of ... The put/call ratio of DRRX is 2.53, ... Vanguard Total Stock Market Index Fund Investor Shares holds 6,635K shares representing 27.10% ...DURECT Corp ( DRRX) is up 3.29% today. DRRX has an Overall Score of 75. Find out what this means to you and get the rest of the rankings on DRRX! DRRX stock closed at $7.00 and is up $0.23 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard …

For DURECT stock forecast for 2026, 12 predictions are offered for each month of 2026 with average DURECT stock forecast of $0.87, a high forecast of $1.25, and a low forecast of $0.48. The average DURECT stock forecast 2026 represents a 39.89% increase from the last price of $0.620000004768372.Our stock price may be volatile, and your investment in our common stock could decline in value. The market prices for securities of healthcare companies in ...The Applied Uv stock price gained 9.13% on the last trading day (Friday, 1st Dec 2023), rising from $0.115 to $0.126. During the last trading day the stock fluctuated 17.43% from a day low at $0.111 to a day high of $0.130. The price has fallen in 6 of the last 10 days and is down by -13.45% for this period. Volume fell on the last day by -337 ...Find the latest Durect Corporation (DRRX) stock forecast, 12-month price target, predictions and analyst recommendations.1.82%. $205.6M. Acura Pharmaceuticals Inc. 0.00%. $66. DRRX | Complete Durect Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full …Nov 14, 2023 · Future criteria checks 2/6. DURECT is forecast to grow earnings and revenue by 16.9% and 47.9% per annum respectively while EPS is expected to grow by 19.9% per annum.

About CohBar Stock (NASDAQ:CWBR) CohBar, Inc., a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; …Mar 7, 2023 · Durect (DRRX) came out with a quarterly loss of $0.46 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to loss of $0.30 per share a year ago. These figures are ...

Zacks Equity Research. A downtrend has been apparent in Durect (DRRX) lately with too much selling pressure. The stock has declined 17.1% over the past four weeks. However, given the fact that it ...Durect Stock Prediction. MAC. 70According to the issued ratings of 4 analysts in the last year, the consensus rating for DURECT stock is Moderate Buy based on the current 2 hold ratings and 2 buy ratings for DRRX. The average twelve-month price prediction for DURECT is $34.25 with a high price target of $41.00 and a low price target of $27.00.Durect Corp (NASDAQ:DRRX) has a beta value of 1.29 and has seen 1.24 million shares traded in the last trading session. The company, currently valued at $14.51M, closed the last trade at $0.53 per share which meant it -0.87% during that session. The DRRX stock price is -1692.45% off its 52-week high ...CUPERTINO, Calif., July 20, 2023 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) ("DURECT"), a biopharmaceutical company focused on developing its epigenetic regulator program for the treatment ...Mar 7, 2023 · Durect (DRRX) came out with a quarterly loss of $0.46 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to loss of $0.30 per share a year ago. These figures are ... marketbeat.com - June 2 at 4:40 AM. Tocqueville Asset Management L.P. Has $316,000 Position in DURECT Co. (NASDAQ:DRRX) marketbeat.com - May 19 at 7:46 AM. Analysts Offer Insights on Healthcare Companies: Durect (DRRX), Pfizer (PFE) and BioVie (BIVI) markets.businessinsider.com - May 18 at 8:46 AM.What is the current Price Target and Forecast for DURECT (DRRX) DURECT (DRRX) (Delayed Data from NSDQ) $0.66 USD +0.01 (1.54%) Updated Nov 24, 2023 12:59 PM …

Great weather can motivate you to get out of the house, while inclement weather can make you feel lethargic. When the weather’s great we want to be outside enjoying it. For the best regional weather forecasts check out AccuWeather.

Nasdaq provides market information on after hours trading daily from 4:15 p.m. ET to 3:30 p.m. ET on the following day. $233.0401 -1.2599 -0.54%. $190.76 +1.07. DURECT Corporation Common Stock ...

NASDAQ Health Care/Life Sciences Compare to Open 0.627 Prior Close 0.62 (11/30/23) 1 Day DRRX 5.13% DJIA 0.82% Russell 2K 2.96% Health Care/Life Sciences 0.38% …Nasdaq Dividend History provides straightforward stock’s historical dividends data. Dividend payout record can be used to gauge the company's long-term performance when analyzing individual stocks.Nasdaq provides market information on after hours trading daily from 4:15 p.m. ET to 3:30 p.m. ET on the following day. $233.0401 -1.2599 -0.54%. $190.76 +1.07. DURECT Corporation Common Stock ...If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.DRRX Fair Price, Target Price, vs SPY, Historical gross margin, operating margin, net margin, ROE, cash flow, revenue and EPS. Financial, growth and cost analysisDurect Corp (DRRX) $0.66 0.01 (1.54%) 13:00 EST DRRX Stock Quote Delayed 30 Minutes.DRRX Overview Stock Screener Earnings Calendar Sectors Nasdaq | DRRX U.S.: Nasdaq Durect Corp. Watch list NEW Set a price target alert Open Last Updated: Nov 24, 2023 1:00 p.m. EST Real... DURECT Corporation Common Stock (DRRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.DRRX stock complete price action . DRRX stock complete financials . DRRX stock momentum . What does the market think about DRRX stock . DRRX stock newest alerts . DRRX stock social trends . DRRX stock prediction . DRRX stock charts . DRRX stock scanner . 5000 alerts + Find Your Next DRRX Trade!Research DURECT's (Nasdaq:DRRX) stock key valuation metrics while comparing it with its industry peers & market side by side. Research DURECT's ... The above table shows the analyst DRRX forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts .../PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) ... The shares of common stock and accompanying warrants are being sold at a combined purchase price of $5.015 per share and accompanying warrant.

Jul 20, 2023 · /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) ... The shares of common stock and accompanying warrants are being sold at a combined purchase price of $5.015 per share and accompanying warrant. Astrotech's stock was trading at $9.99 at the beginning of 2023. Since then, ASTC shares have decreased by 20.9% and is now trading at $7.90. View the best growth stocks for 2023 here.See DURECT Corporation (DRRX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Instagram:https://instagram. dvnstocksoundhound ai inc. stock pricetsla stockchartspst stock Apr 24, 2023 · Analyst Price Forecast Suggests 670.31% Upside. As of April 24, 2023, the average one-year price target for Durect is 36.98. The forecasts range from a low of 32.32 to a high of $46.20. The ... stock outlookinsider.tmobile Durect Corp (DRRX) $0.66 0.01 (1.54%) 13:00 EST DRRX Stock Quote Delayed 30 Minutes.NASDAQ Health Care/Life Sciences Compare to Open 0.627 Prior Close 0.62 (11/30/23) 1 Day DRRX 5.13% DJIA 0.82% Russell 2K 2.96% Health Care/Life Sciences 0.38% … otcmkts hnoi Feb 3, 2023 · The shares of common stock and accompanying warrants are being sold at a combined purchase price of $5.00 per share and accompanying warrant, and the pre-funded warrants are being sold at a ... Planning a trip can be an exciting but challenging task. From booking accommodations to creating an itinerary, there are countless details to consider. One crucial aspect that should never be overlooked is checking the 7-day weather forecas...